Skrepnek, G. H., Seal B., Tangirala M., Jeffcoat M. K., Watts N. B., & Hay J. W. (2009). Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. General dentistry. 58(6), 484-92; quiz 493-4.

S. Olshansky, J., Goldman D. P., Zheng Y., & Rowe J. W. (2009). Aging in America in the Twenty-first Century: Demographic Forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Quarterly. 87(4), 842-862.

Stewart, K. A., Grabowski D. C., & Lakdawalla D. N. (2009). Annual expenditures for nursing home care: Private and public payer price growth, 1977–2004. Medical care. 47(3), 295-301.

Antos, J., Bertko J., Chernew M. E., Cutler D. M., Goldman D. P., McClellan M., et al. (2009). Bending the curve: effective steps to address long-term healthcare spending growth. The American Journal of Managed Care. 15(10), 676-680.

Goldman, D. P., Lakdawalla D. N., Romley J. A., Malkin J. D., & Philipson T. J. (2009). The Benefits of Greater Data Exclusivity under the Hatch-Waxman Act.

Goldman, D. P., Zheng Y., Girosi F., Michaud P-C., S. Olshansky J., Cutler D. M., et al. (2009). The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older. American Journal of Public Health. 99(11), 2096-2101.

Huesch, M. D. (2009). Can managed care plans reliably infer the quality of cardiac surgeons’ outcomes? The American Journal of Managed Care. 15(12), 890-896.

Crimmins, E. M., Hayward M. D., Hagedorn A., Saito Y., & Brouard N. (2009). Change in disability-free life expectancy for Americans 70 years old and older*. Demography. 46(3), 627-646.

Ruelas, V., G. Roybal M., Lu Y., Goldman D. P., & Peters A. L. (2009). Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes. Diabetes Care. 32(1), 54-56.

Cherry, S. B., Benner J. S., Hussein M. A., Tang S. S. K., & Nichol M. B. (2009). The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients. Value in Health. 12(4), 489-497.

Huesch, M. D. (2009). Comment on “The Diffusion of a Medical Innovation: Is Success in the Stars?”. Southern Economic Journal. 75(4), 1270-1273.

Gu, N. Yan, Wolf C. F., Leopold S. S., Manner P. A., & Doctor J. N. (2009). A Comparison of Physician and Patient Time Trade-Offs for Postoperative Hip Outcomes. Value in Health. 12(4), 618-620.

Robinson, J. C., & Ginsburg P. B. (2009). Consumer-Driven Health Care: Promise And Performance. Health Affairs. 28(2), w272-w281.

Hay, J. W., Jhaveri M., Tangirala M., & Kaliner M. A. (2009). Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment. Allergy and Asthma Proceedings. 30(6), 634-642.

Hay, J. W., Lawler E., Yucel K., Guo A., Balzer T., Gaziano J. Michael, et al. (2009). Cost Impact of Diagnostic Imaging for Lower Extremity Peripheral Vascular Occlusive Disease. Value in Health. 12(2), 262-266.

Solomon, M. D., Goldman D. P., Joyce G. F., & Escarce J. J. (2009). Cost sharing and the initiation of drug therapy for the chronically ill. Archives of Internal Medicine. 169(8), 740-748.

Le, Q. A., & Hay J. W. (2009). Cost-effectiveness analysis of lapatinib in HER-2–positive advanced breast cancer. Cancer. 115(3), 489-498.

Hay, J. W., & Kaliner M. A. (2009). Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective. Current Medical Research and Opinion. 25(6), 1421-1431.

Smith, W. P., Doctor J. N., Meyer J., Kalet I. J., & Phillips M. H. (2009). A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model. Artificial Intelligence in Medicine. 46(2), 119-130.

Chernew, M. E., Goldman D. P., Pan F., & Shan B. (2009). Disability and Spending Growth. Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly. 237-248.

Sharp, E. Schoenhofe, Suthers K. M., Crimmins E. M., & Gatz M. (2009). Does “No” Mean “Sometimes”? How Older Adults Respond to the Same Depression Symptoms with Different Response Formats. Clinical Gerontologist. 32(4), 371-378.

Merkin, S. Stein, Karlamangla A. S., Crimmins E. M., Charette S. L., Hayward M. D., Kim J. Ki, et al. (2009). Education differentials by race and ethnicity in the diagnosis and management of hypercholesterolemia: a national sample of U.S. adults (NHANES 1999–2002). International Journal of Public Health. 54(3), 166-174.

Sood, N., de Vries H., Gutierrez I., Lakdawalla D. N., & Goldman D. P. (2009). The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries. Health Affairs. 28(1), w125-w137.

Asch, B. J., Haider S. J., & Zissimopoulos J. M. (2009). The Effects of Workforce-Shaping Tools on Retirement: The Case of the Department of Defense Civil Service. Journal of Public Health Management and Practice. 15(Supplement), S64-S72.

Romley, J. A., Hussey P. S., de Vries H., Wang M. C., Shekelle P. G., & McGlynn E. A. (2009). Efficiency and its measurement: what practitioners need to know. The American Journal of Managed Care. 15(11), 842-845.

Sood, N., Ghosh A., & Escarce J. J. (2009). Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries. Health Services Research. 44(5p1), 1449-1464.

Cella, D., Nichol M. B., Eton D., Nelson J. B., & Mulani P. (2009). Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer. Value in Health. 12(1), 124-129.

Nichol, M. B., Knight T. K., Wu J., Barron R., & Penson D. F. (2009). Evaluating Use Patterns of and Adherence to Medications for Benign Prostatic Hyperplasia. The Journal of Urology. 181(5), 2214-2222.

Goldman, D. P., Lakdawalla D. N., & Zheng Y. (2009). Food Prices and the Dynamics of Body Weight.

Huesch, M. D., & Sakakibara M. (2009). Forgetting the learning curve for a moment: how much performance is un related to own experience? Health Economics. 18(7), 855-862.

Gwadry-Sridhar, F. H., Manias E., Zhang Y., Roy A., Yu-Isenberg K., Hughes D. A., et al. (2009). A framework for planning and critiquing medication compliance and persistence research using prospective study designs. Clinical Therapeutics. 31(2), 421-435.

Chapman, R. H., Benner J. S., Girase P., Benigno M., Axelsen K., Liu L. Z., et al. (2009). Generic and therapeutic statin switches and disruptions in therapy. Current Medical Research and Opinion. 25(5), 1247-1260.

Ginsburg, P. B. (2009). Getting to the Real Issues in Health Care Reform. New England Journal of Medicine. 361(22), 2107-2109.

Lakdawalla, D. N., & Philipson T. J. (2009). The growth of obesity and technological change. Economics & Human Biology. 7(3), 283-293.

Aaron, H. J., & Ginsburg P. B. (2009). Is Health Spending Excessive? If So, What Can We Do About It? Health Affairs. 28(5), 1260-1275.

Marshall, T. S., McCombs J. S., & Stafkey-Mailey D. (2009). Impact of Patient Selection Criteria and Treatment History on Comparisons of Alternative Therapies: A Case Study of Atypical Antipsychotics. Value in Health. 12(4), 473-480.

November, E. A., Cohen G. R., Ginsburg P. B., & Quinn B. C. (2009). Individual insurance: health insurers try to tap potential market growth. Research Brief. 1-8.

Gurven, M., Kaplan H., Winking J., Rodriguez D. Eid, Vasunilashorn S., Kim J. Ki, et al. (2009). Inflammation and Infection Do Not Promote Arterial Aging and Cardiovascular Disease Risk Factors among Lean Horticulturalists. PLoS ONE. 4(8), e6590.

Sox, C. M., Doctor J. N., Koepsell T. D., & Christakis D. A. (2009). The influence of types of decision support on physicians’ decision making. Archives of Disease in Childhood.

Lakdawalla, D. N., & Sood N. (2009). Innovation and the welfare effects of public drug insurance. Journal of Public Economics. 93(3–4), 541-548.

Michaud, P-C., Goldman D. P., Lakdawalla D. N., Gailey A. H., & Zheng Y. (2009). International Differences in Longevity and Health and their Economic Consequences.

Huesch, M. D. (2009). Learning by ng, Scale Effects, or Neither? Cardiac Surgeons after Residency. Health Services Research. 44(6), 1960-1982.

Bhattacharya, J., Goldman D. P., & Sood N. (2009). Market evidence of misperceived mortality risk. Journal of Economic Behavior & Organization. 72(1), 451-462.

Pham, H. H., Ginsburg P. B., & Verdier J. M. (2009). Medicare Governance And Provider Payment Policy. Health Affairs. 28(5), 1382-1394.

Joyce, G. F., Goldman D. P., Vogt W. B., Sun E. C., & Jena A. B. (2009). Medicare Part D After Two Years. The American Journal of Managed Care. 15(8), 536-544.

Crimmins, E. M., Kim J. Ki, & Seeman T. E. (2009). Poverty and Biological Risk: The Earlier “Aging” of the Poor. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 64A(2), 286-292.

Goldman, D. P., Joyce G. F., Karaca-Mandic P., Vogt W. B., Sun E. C., Jena A. B., et al. (2009). Prescription Drug Cost Sharing. RAND Research Briefs.

Maestas, N., Schroeder M., & Goldman D. P. (2009). Price Variation in Markets with Homogeneous Goods: The Case of Medigap.

Hussey, P. S., de Vries H., Romley J. A., Wang M. C., Chen S. S., Shekelle P. G., et al. (2009). A Systematic Review of Health Care Efficiency Measures. Health Services Research. 44(3), 784-805.

Arrow, K., Auerbach A., Bertko J., Brownlee S., Casalino L. P., Cooper J., et al. (2009). Toward a 21st-Century Health Care System: Recommendations for Health Care Reform. Annals of Internal Medicine. 150(7), 493-495.

Nichol, M. B., Knight T. K., Wu J., Tang S. S. K., Cherry S. B., Benner J. S., et al. (2009). Transition Probabilities and Predictors of Adherence in a California Medicaid Population Using Antihypertensive and Lipid-Lowering Medications. Value in Health. 12(4), 544-550.

Michaud, P-C., Goldman D. P., Lakdawalla D. N., Zheng Y., & Gailey A. H. (2009). Understanding the Economic Consequences of Shifting Trends in Population Health.

Lakdawalla, D. N., Goldman D. P., Michaud P-C., Sood N., Lempert R., Cong Z., et al. (2009). U.S. Pharmaceutical Policy In A Global Marketplace. Health Affairs. 28(1), w138-w150.

Doctor, J. N., Miyamoto J., & Bleichrodt H. (2009). When are person tradeoffs valid? Journal of Health Economics. 28(5), 1018-1027.

Loughran, D. S., & Zissimopoulos J. M. (2009). Why Wait? The Effect of Marriage and Childbearing on the Wages of Men and Women. Journal of Human Resources. 44(2), 326-349.

Lawless, G. D. (2009). The Working Patient with Cancer: Implications for Payers and Employers. American Health & Drug Benefits. 2(4), 168-173.